Synthetic antioxidant l-ergothioneine safe as a novel food for pregnant women and children: EFSA

e93600d1-0d90-41a7-8135-378c762211dcarticleimage.jpg

24 Nov 2017 --- The European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) has concluded that synthetic l-ergothioneine is safe under the proposed uses and use levels for the groups of the population which had been excluded by the applicant in the original application. Following a request from the European Commission, EFSA confirmed the safety of the powerful antioxidant for groups including infants, young children (i.e. toddlers), pregnant women and breastfeeding women.

On 26 October, 2016, the EFSA NDA panel adopted the scientific opinion on the safety of synthetic l-ergothioneine as a novel food pursuant to Regulation (EC) No 258/97.

In performing the safety assessment of the novel food, the NDA panel considered the proposed uses (i.e. food ingredient added to alcohol-free beverages; milk; “fresh” dairy products; cereal bars and chocolate; food supplements) and the proposed target population (i.e. children above 3 years of age and the general adult population, with the exception of pregnant and breastfeeding women).

Detailed information on the safety assessment of synthetic l-ergothioneine is provided in the published opinion which informs on the specifications of the novel food, its stability, the production process, the anticipated intake/extent of use in the proposed target population, nutritional information of the novel food, microbiological information, toxicological information (including absorption, distribution, metabolism and excretion), human studies and potential allergenicity of the novel food.

In 2016, the NDA panel considered a no-observed-adverse-effect level (NOAEL) of 800 mg/kg body weight (bw) per day of the novel food. Taking into account this NOAEL and the maximum estimated intake levels for l-ergothioneine from all sources (i.e. fortified foods, food supplements and background diet) of 1.7 mg/kg bw per day for adults and of 3.7 mg/kg bw per day for children, the panel concluded that the margins of safety of 470 for adults (excluding pregnant and breastfeeding women) and of 216 for children above 3 years of age are sufficient.

Findings extend to additional groups
For the latest assessment, intake estimates were calculated for the specified groups and the following maximum anticipated daily intakes of l-ergothioneine from the NF, in addition to the background diet, were calculated: 2.82 mg/kg body weight (bw) per day for infants, 3.39 mg/kg bw per day for toddlers and 1.31 mg/kg bw per day for adults including pregnant and breastfeeding women.

The panel states that based on the overall toxicological data, the no-observed-adverse-effect level (NOAEL) of 800 mg/kg bw per day as established in the original assessment also pertains to pregnant and breastfeeding women as well as to young children (i.e., toddlers) and infants.

The corresponding margins of exposure (i.e., the ratio between the NOAEL and the maximum anticipated daily intakes) are 284 for infants, 236 for young children and 610 for pregnant and breastfeeding women. These margins of exposure are considered sufficient.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Nutrition & Health News

US FDA takes action against OTC benzocaine products for teething infants

24 May 2018 --- The US Food and Drug Administration (FDA) has warned that over-the-counter (OTC) teething products containing benzocaine may pose a serious risk to infants and children. The popular numbing agent can offer temporary relief to sore gums in teething infants; however, the FDA advises that companies stop marketing and selling these products for use. The agency is also raising awareness of the risks that, they state, come with other oral health benzocaine products. 

Nutrition & Health News

UK sugar reduction efforts fail to reach initial target, industry urged to step up or face tax

23 May 2018 --- The first assessment of the UK government’s sugar reduction program has unveiled failings by industry to reduce sugar in the first year by 5 percent, leading to calls of a sugar tax on sweet treats. The results of the first year have been roundly criticized in the media and described as “hugely disappointing” after Public Health England data revealed that sugar was cut in some categories – sweet spreads and sauces, yogurts and fromage frais and breakfast cereals – while other food groups have fallen short.

Nutrition & Health News

Diabetes UK: “Consumers want to see clearer calorie labeling on food and menus” 

23 May 2018 --- Consumers are more likely to purchase food if it is accompanied by clear calorie labels on its packaging or on the menu of the establishment, a survey conducted by Diabetes UK’s campaign, Food Upfront, has found. The survey sheds light on how the availability of clear labeling on food and drink could have considerable influence on the spending habits of the British public. Therefore, the campaign is calling for mandatory front-of-pack traffic light labeling on foods and menu calorie labeling in eating establishments.

Nutrition & Health News

Top companies reflect mixed progress on commitment to global nutrition, ranking shows

23 May 2018 --- Nestlé has nabbed the highest ranking spot in the 2018 Access to Nutrition Index (ATNI), reflecting its overall performance in nutrition-related commitments. Meanwhile, FrieslandCampina has improved the most since 2016, climbing four places in the ranking largely thanks to a new strategy to tackle under-nutrition and more responsible marketing commitments. However, the ATNI state that many companies are still doing too little in the realm of nutrition. The ATNI is the third Global Index that ranks the world’s 22 largest food and beverage companies on their contributions to addressing the twin global nutrition challenges of overweight and diet-related diseases and under-nutrition. 

Nutrition & Health News

Marealis’ novel shrimp peptide gains EFSA green light

22 May 2018 --- The European Food Safety Authority (EFSA) has approved an application for the novel food status of a shrimp peptide concentrate, meaning that the ingredient can now be utilized in EU supplement applications. The application was made by the company Medfiles Ltd. on behalf of Marealis, a developer of science-backed nutraceuticals. The supplements will be marketed to those who want to address the problem of prehypertension in the Marealis product, PreCardix.

More Articles
URL : http://www.nutritioninsight.com:80/news/synthetic-antioxidant-l-ergothioneine-safe-as-a-novel-food-for-pregnant-women-and-children-efsa.html